Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia
NCT01352897 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2011-05-12
Summary
The objective of this follow-up retrospective study is to evaluate the long term efficacy and safety of rosuvastatin in reducing lipid parameters in clinical practice.
Conditions
- Hypercholesterolaemia
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
DR ARTHUR TAN, MBBS · ARTHUR TAN HEART CLINIC, GLENEAGLES MEDICAL CENTRE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2010-12-31
- Completion
- 2010-12-31
Countries
- Singapore
Study Locations
More Related Trials
-
Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
NCT00296387 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia
NCT01420549 ·Status: COMPLETED ·Phase: PHASE3
-
Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome
NCT00335699 ·Status: COMPLETED ·Phase: PHASE4
-
Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg
NCT00653445 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients
NCT02251847 ·Status: UNKNOWN ·Phase: PHASE3
-
IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin
NCT00654446 ·Status: COMPLETED ·Phase: PHASE3
-
Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients
NCT00695539 ·Status: COMPLETED
-
Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy
NCT00239330 ·Status: COMPLETED ·Phase: PHASE3
-
Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)
NCT00651378 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia
NCT03571087 ·Status: COMPLETED ·Phase: PHASE3
-
COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects
NCT00654485 ·Status: COMPLETED ·Phase: PHASE3
-
12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe
NCT00525824 ·Status: COMPLETED ·Phase: PHASE3
-
Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease
NCT00329160 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR)
NCT00654173 ·Status: COMPLETED ·Phase: PHASE3
-
To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia
NCT00726362 ·Status: COMPLETED
-
A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)
NCT00240318 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
NCT00296400 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
NCT00665834 ·Status: COMPLETED ·Phase: PHASE4
-
30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease
NCT00680017 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg
NCT00427960 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Rosuvastatin Therapy on HDL2 Level
NCT02593487 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia
NCT03288038 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
NCT06186037 ·Status: RECRUITING ·Phase: PHASE4
-
A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.
NCT01138072 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Crestor® (Rosuvastatin) in Daily Practice
NCT00837083 ·Status: COMPLETED